Episode 5 - CE 1 - Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction

PAWNYCast

Drs. Vicky Belousova, Alyssa Wozniak, and Gurjot Sandhu discuss the newly published Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF) trial, otherwise known as the Emperor Preserved Trial.

By listening to this episode, pharmacists in all practice settings may be eligible to receive 0.5 contact hours (0.05 CEU) of continuing education credit.

Fees: non-PAWNY members: $15.00, PAWNY members: $10.00

Sign up here:

https://dyouville.catalog.instructure.com/courses/evidence-for-the-use-of-empagliflozin-in-heart-failure-with-preserved-ejection-fraction-hfpef

Connect with us

  • Email: pawnycast@gmail.com with your feedback and ideas for the podcast
  • Social Media: check us out on Facebook and Instagram
  • Website: pawnyrx.org
  • Subscribe to our podcast to never miss a new episode and leave a review
  • Be sure to like and review us on your favorite podcasting app!

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign-in or sign-up to follow shows, save episodes and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada